Erratum: Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial

Erratum: Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trial

Nature Reviews Immunology 31 Aug 2012 (doi:10.1038/nri3192-c1) On page 2 of the original Correspondence article, under the subheading “Failure to reconcile discordant preclinical data”, the dose of 5.11A1 administered to HIS mice in the study by Legrand et al. was incorrectly stated as 0.3 mg per kg...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature reviews. Immunology 2012-09, Vol.12 (10), p.740-740
Hauptverfasser: Horvath, Christopher, Andrews, Laura, Baumann, Andreas, Black, Lauren, Blanset, Diann, Cavagnaro, Joy, Hastings, Kenneth L., Hutto, David L., MacLachlan, Timothy K., Milton, Mark, Reynolds, Theresa, Roberts, Stan, Rogge, Mark, Sims, Jennifer, Treacy, George, Warner, Garvin, Green, James D.
Format: Artikel
Sprache:eng
Schlagworte:
692/700/565/2194
Biomedical and Life Sciences
Biomedicine
corrigendum
Erratum
Immunology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Nature Reviews Immunology 31 Aug 2012 (doi:10.1038/nri3192-c1) On page 2 of the original Correspondence article, under the subheading “Failure to reconcile discordant preclinical data”, the dose of 5.11A1 administered to HIS mice in the study by Legrand et al. was incorrectly stated as 0.3 mg per kg, when it should have been 0.
ISSN:1474-1733
1474-1741
DOI:10.1038/nri3302